Indaptus Therapeutics, Inc.(NASDAQ:INDP) 
Indaptus Therapeutics, Inc., a pre-clinical stage biotech company, develops a patented anti-cancer and antiviral immunotherapy. It engages in developing a pre-clinical pipeline of therapeutic candidates intended to elicit anti-tumor and anti-viral responses, as well as cure diseases. The company's l...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 13.45
H 13.45
L 12.89
C 12.89
V 101,026
10EMA 12.89
20EMA 12.89
60EMA 12.89
120EMA 12.89
250EMA 12.89